<DOC>
	<DOCNO>NCT00958243</DOCNO>
	<brief_summary>The purpose study evaluate immunogenicity safety profile CSL425 ( CSL 's 2009 H1N1 influenza vaccine ) healthy pediatric population .</brief_summary>
	<brief_title>A Clinical Trial CSL 's 2009 H1N1 Influenza Vaccine ( CSL425 ) Healthy Pediatric Population USA</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female age &gt; = 6 month &lt; 9 year time first study vaccination . For child &lt; 3 year age time first vaccination , born 36 week gestation . Known hypersensitivity previous dose influenza virus vaccine allergy egg , chicken protein , neomycin , polymyxin , component Study Vaccine</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>